The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Pfizer and Headlands Health Partner to Increase Clinical Trial Diversity
Clinical trial participants are often far less diverse than the populations they represent, as clinical trial sites are often located [...]
Sanofi Launches Industry’s First Diversity, Equity, and Inclusion Board with Outside Advisor
The multinational pharmaceutical corporation Sanofi has launched its new Diversity, Equity, and Inclusion (DE&I) Board, the first of its kind [...]
Medical Affairs Podcast: Increasing Diversity in Clinical Trials
A lack of participant diversity in clinical trials exacerbates health disparity by limiting the applicability of new drugs to marginalized [...]
AbbVie HEOR Expert Notes Lack of Diversity Negatively Impacts Clinical Trials, RWD Offers Possible Solution
Vice President and Global Head of Health Economics and Outcomes Research (HEOR) at AbbVie Dr. Chris Boone notes that the [...]
Gaps in Health Data are Barrier to Health Equity
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / [...]
Race Rarely at Top of Patient’s Medical Record
Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not [...]
Employee Health Data Analyses Must Include Race And Ethnicity
As the COVID-19 pandemic has highlighted, at the core of racial equity and social justice movements are health disparities along [...]
ICER Releases Statement on Racism in America
The Institute for Clinical and Economic Review (ICER) has pledged to do its part to combat institutionalized and systemic racism. [...]
[E-Book] Representation and diversity in clinical trials
As clinical trials are the gold standard for evidence-based medicine, it is essential for researchers to be as inclusive as [...]
JMCP’s Call to Action in Addressing Racial Disparities in Medication Use
In a recently published article, the editorial team at 'Journal of Managed Care + Specialty Pharmacy' (JMCP) raised the question [...]
[Webinar] Towards Greater Diversity in Clinical Trials and Health Plan Networks
Join HealthVerity on Thursday, October 15th, 2020 at 12:00 PM EDT for an in-depth discussion on the challenges of recruiting [...]